Investing in Ex Ante Regulation: Evidence From Pharmaceutical Patent Examination
Publication
, Journal Article
Frakes, MD; Wasserman, MF
Published in: American Economic Journal: Economic Policy
2023
Duke Scholars
Published In
American Economic Journal: Economic Policy
Publication Date
2023
Volume
15
Issue
3
Start / End Page
151 / 183
Related Subject Headings
- 1402 Applied Economics
Citation
APA
Chicago
ICMJE
MLA
NLM
Frakes, M. D., & Wasserman, M. F. (2023). Investing in Ex Ante Regulation: Evidence From Pharmaceutical Patent Examination. American Economic Journal: Economic Policy, 15(3), 151–183.
Frakes, Michael D., and Melissa F. Wasserman. “Investing in Ex Ante Regulation: Evidence From Pharmaceutical Patent Examination.” American Economic Journal: Economic Policy 15, no. 3 (2023): 151–83.
Frakes MD, Wasserman MF. Investing in Ex Ante Regulation: Evidence From Pharmaceutical Patent Examination. American Economic Journal: Economic Policy. 2023;15(3):151–83.
Frakes, Michael D., and Melissa F. Wasserman. “Investing in Ex Ante Regulation: Evidence From Pharmaceutical Patent Examination.” American Economic Journal: Economic Policy, vol. 15, no. 3, 2023, pp. 151–83.
Frakes MD, Wasserman MF. Investing in Ex Ante Regulation: Evidence From Pharmaceutical Patent Examination. American Economic Journal: Economic Policy. 2023;15(3):151–183.
Published In
American Economic Journal: Economic Policy
Publication Date
2023
Volume
15
Issue
3
Start / End Page
151 / 183
Related Subject Headings
- 1402 Applied Economics